lifestyle.womensconference.org

Author: Insight Molecular Diagnostics Inc.

Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay

April 28, 2026
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

March 20, 2026
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score

March 13, 2026
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission

March 3, 2026
iMDx Announces $26.0 Million Registered Direct Offering

February 11, 2026